Dr. Pooli earned his medical degree from Tehran University of Medical Sciences (TUMS). He subsequently completed his urology residency at University of Nebraska Medical Center (UNMC) and urologic oncology fellowship training at UCLA's Institute of Urologic Oncology (IUO), David Geffen School of Medicine. His primary research interests include working on gene expression protocols for high risk prostate and kidney cancers. His clinical work focuses on patient-centered management of urologic cancers as well as delivery of targeted therapies and tailored surgical procedures.